▲ Peaking
Health
Antithrombotic Therapy After TAVI
New clinical data from the ACASA-TAVI trial suggests a shift toward NOAC monotherapy to reduce valve clots after heart valve replacement.
Noac
1 trends tracked about this subject — the full history, oldest to newest below.